Actinium Ac 225 DOTATATE RYZ101 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: 225Ac-DOTA-TATE RYZ101, 225Ac-Oxodotreotide, ACTINIUM AC-225 DOTATATE, Actinium Ac 225-Dotatate RYZ101, RYZ 101, RYZ-101, RYZ101

Filter by location:

Columbus, Ohio1 trial

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Ohio State University Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.